Erika Timmer

1.0k total citations
26 papers, 789 citations indexed

About

Erika Timmer is a scholar working on Molecular Biology, Epidemiology and Neurology. According to data from OpenAlex, Erika Timmer has authored 26 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in Erika Timmer's work include Neuroendocrine Tumor Research Advances (6 papers), Neuroblastoma Research and Treatments (5 papers) and Mitochondrial Function and Pathology (4 papers). Erika Timmer is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Neuroblastoma Research and Treatments (5 papers) and Mitochondrial Function and Pathology (4 papers). Erika Timmer collaborates with scholars based in Netherlands, Belgium and United States. Erika Timmer's co-authors include Frans C. S. Ramaekers, Gert Schaart, Guillaume J. van Eys, Anton Roebroek, Freya Dittmann‐Kohli, Hubert J.M. Smeets, L.A.H. Monnens, Nicole H. M. Senden, Wim J.M. Van de Ven and H.J.M. Smeets and has published in prestigious journals such as The Journal of Cell Biology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Erika Timmer

24 papers receiving 766 citations

Peers

Erika Timmer
Kristine Kelly United States
J R Westphal Netherlands
Jennifer Harman United States
Robert J. Tower United States
Qiong Gan United States
Shahla M. Jilani United States
Kristine Kelly United States
Erika Timmer
Citations per year, relative to Erika Timmer Erika Timmer (= 1×) peers Kristine Kelly

Countries citing papers authored by Erika Timmer

Since Specialization
Citations

This map shows the geographic impact of Erika Timmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Timmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Timmer more than expected).

Fields of papers citing papers by Erika Timmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Timmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Timmer. The network helps show where Erika Timmer may publish in the future.

Co-authorship network of co-authors of Erika Timmer

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Timmer. A scholar is included among the top collaborators of Erika Timmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Timmer. Erika Timmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tienen, Florence H. J. van, Janneke G. J. Hoeijmakers, Christiaan van der Leij, et al.. (2025). Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1/2 human clinical study. Molecular Therapy. 33(10). 5061–5072.
2.
Timmer, Erika, et al.. (2023). Fusion of Wild-Type Mesoangioblasts with Myotubes of mtDNA Mutation Carriers Leads to a Proportional Reduction in mtDNA Mutation Load. International Journal of Molecular Sciences. 24(3). 2679–2679. 4 indexed citations
3.
Timmer, Erika, Patrick Lindsey, Mattia Quattrocelli, et al.. (2019). Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy. Stem Cell Research & Therapy. 10(1). 405–405. 13 indexed citations
4.
Voets, A.M., Patrick Lindsey, Erika Timmer, et al.. (2012). Patient-derived fibroblasts indicate oxidative stress status and may justify antioxidant therapy in OXPHOS disorders. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1817(11). 1971–1978. 18 indexed citations
5.
Martherus, Ruben, et al.. (2010). Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association. Biochemical and Biophysical Research Communications. 402(2). 203–208. 33 indexed citations
6.
Martherus, Ruben, Erika Timmer, Volkert A. Zeijlemaker, et al.. (2010). Electrical signals affect the cardiomyocyte transcriptome independently of contraction. Physiological Genomics. 42A(4). 283–289. 30 indexed citations
7.
Timmer, Erika, Nardi Steverink, Nan Stevens, & Freya Dittmann‐Kohli. (2003). Personal concepts of stability in the second half of life. Journal of Aging Studies. 17(4). 427–443. 14 indexed citations
8.
Timmer, Erika & Marja Aartsen. (2003). MASTERY BELIEFS AND PRODUCTIVE LEISURE ACTIVITIES IN THE THIRD AGE. Social Behavior and Personality An International Journal. 31(7). 643–656. 14 indexed citations
9.
Timmer, Erika, Nardi Steverink, & Freya Dittmann‐Kohli. (2002). Cognitive Representations of Future Gains, Maintenance, and Losses in the Second Half of Life. The International Journal of Aging and Human Development. 55(4). 321–339. 13 indexed citations
10.
Heidet, Laurence, Erika Timmer, B.J.C. van den Bosch, et al.. (2000). Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney International. 58(5). 1870–1875. 104 indexed citations
11.
Heidet, Laurence, Erika Timmer, B.J.C. van den Bosch, et al.. (2000). Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney International. 58(5). 1870–1875. 1 indexed citations
12.
Monnens, L.A.H., et al.. (1999). Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney International. 55(4). 1217–1224. 43 indexed citations
13.
Senden, Nicole H. M., Erika Timmer, Adriaan de Bruı̈ne, et al.. (1997). A COMPARISON OF NSP-RETICULONS WITH CONVENTIONAL NEUROENDOCRINE MARKERS IN IMMUNOPHENOTYPING OF LUNG CANCERS. The Journal of Pathology. 182(1). 13–21. 17 indexed citations
14.
Senden, Nicole H. M., Erika Timmer, Helgi van de Velde, et al.. (1997). Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. Histochemistry and Cell Biology. 108(2). 155–165. 17 indexed citations
15.
Schaart, Gert, et al.. (1996). Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells.. The Journal of Cell Biology. 134(2). 401–411. 211 indexed citations
16.
Senden, Nicole H. M., Helgi J. K. van de Velde, Jos L. V. Broers, et al.. (1994). Cluster-10 lung-cancer antibodies recognize NSPs, novel neuro-endocrine proteins associated with membranes of the endoplasmic reticulum. International Journal of Cancer. 57(S8). 84–88. 13 indexed citations
17.
Moors, Ellen H.M., A. B. Johan Groeneveld, Erika Timmer, et al.. (1992). Monoclonal antibody MON-114: detection of a marker for neuroendocrine differentiation in human lung cancer. Cancer Letters. 63(1). 61–66. 1 indexed citations
18.
Schalkwijk, Joost, Ivonne M.J.J. van Vlijmen‐Willems, A. B. Johan Groeneveld, et al.. (1992). MON-150, a versatile monoclonal antibody against involucrin: characterization and applications. Archives of Dermatological Research. 284(3). 167–172. 26 indexed citations
19.
Creemers, John W.M., Erika Timmer, A. B. Johan Groeneveld, et al.. (1992). Development and Characterization of a Panel of Monoclonal Antibodies Against the Novel Subtilisin-Like Proprotein Processing Enzyme Furin. Hybridoma. 11(1). 71–86. 40 indexed citations
20.
Duijnhoven, Hans L. P. van, Martie C. M. Verschuren, Erika Timmer, et al.. (1991). Application of recombinant DNA technology in epitope mapping and targeting. Journal of Immunological Methods. 142(2). 187–198. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026